Ovarian Cancer: Recurrence After PARP Inhibition

0 Pogledi
administrator
administrator
07/08/23

Strategies for approaching patients with ovarian cancer who report a recurrence following treatment with a PARP inhibitor.

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći